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ABSTRACT
The polypurine/polypyrimidine (pPu/pPy) tract of the
human vascular endothelial growth factor (VEGF)
gene is proposed to be structurally dynamic and to
have potential to adopt non-B DNA structures. In the
present study, we further provide evidence for the
existence of the G-quadruplex structure within this
tract both in vitro and in vivo using the dimethyl
sulfate (DMS) footprinting technique and nucleolin
as a structural probe specifically recognizing
G-quadruplex structures. We observed that the
overall reactivity of the guanine residues within
this tract toward DMS was significantly reduced
compared with other guanine residues of the
flanking regions in both in vitro and in vivo footprint-
ing experiments. We also demonstrated that
nucleolin, which is known to bind to G-quadruplex
structures, is able to bind specifically to the G-rich
sequence of this region in negatively supercoiled
DNA. Our chromatin immunoprecipitation analysis
further revealed binding of nucleolin to the
promoter region of the VEGF gene in vivo. Taken
together, our results are in agreement with our hy-
pothesis that secondary DNA structures, such as
G-quadruplexes, can be formed in supercoiled
duplex DNA and DNA in chromatin in vivo under
physiological conditions similar to those formed in
single-stranded DNA templates.
INTRODUCTION
The switch to an angiogenic phenotype in cancer cells
is often mediated by increased expression of vascular
endothelial growth factor (VEGF), which is a pluripotent
cytokine and angiogenic growth factor (1–3). VEGF
consists of two identical subunits and it binds to VEGF
receptors on the surfaces of endothelial cells (4). The inter-
action of VEGF and its cognate receptors stimulates the
proliferation, migration, survival and permeability of
endothelial cells, promoting the formation of new blood
vessels (1–3). VEGF expression, which is frequently
elevated in many types of cancer (1–3), is mainly regulated
at the transcriptional level (5) and its expression is induced
by a variety of factors, including hypoxia, pH, activated
oncogenes, inactivated tumor suppressor genes and
growth factors (6–9). The molecular basis of VEGF gene
expression has been extensively studied by characterizing
the cis-acting elements and transcription factors involved
in constitutive VEGF expression in human cancer cells
(10). This study revealed that the proximal 36-bp region
(–85 to  50 relative to transcription initiation site) is es-
sential for basal or inducible VEGF promoter activity in
several human cancer cell lines (Figure 1A). These cis-
regulatory elements contain at least three Sp1 binding
sites, which consist of a polypurine/polypyrimidine (pPu/
pPy) sequence. The pPu/pPy tracts are overly represented
in the proximal promoter region of many TATA-less
mammalian genes, including EGF-R, c-Myc, VEGF,
HIF-1a, c-Myb, malic enzyme, I-R, AR, c-Src, c-Ki-Ras,
TGFb and PDGF A-chain (11–13). These sequences have
been proposed to be very dynamic in their conformation,
easily adopting non-B-DNA conformations, such as
melted DNA, hairpin structures, slipped helices or
others, under physiological conditions, when there is
negative supercoiling (14–18). In particular, G-rich se-
quences of these tracts have been reported to form
parallel or antiparallel G-quadruplex structures consisting
of two or more G-tetrads in the presence of monovalent
cations such as Na
+and K
+, as shown in Figure 1B (19).
Signiﬁcantly, the polypurine (guanine) tract of the VEGF
promoter contains at least four runs of three or more con-
tiguous guanines separated by one or more bases, corres-
ponding to a general motif capable of forming an
intramolecular G-quadruplex: VEGF: 50-G4 (C) G3 (CC)
G5 (C) G4 (TCCCGGC) G4 (CGG)-30 (18,20). Using the
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sulfate (DMS) footprinting, the DNA polymerase stop
assay, circular dichroism (CD) spectroscopy and molecu-
lar modeling (20), our previous studies demonstrated that
the G-rich strand in this tract within the VEGF proximal
promoter is indeed capable of forming intramolecular
parallel G-quadruplex structures in vitro in the presence
of K
+ (Figure 1C) which can be further stabilized by
various G-quadruplex interactive agents (20). We also
demonstrated the dynamic nature of this tract in the
VEGF promoter region using in vitro footprinting experi-
ments with DNase I and S1 nuclease (18). Furthermore,
the same study revealed that the identical changes in foot-
printing patterns by both nucleases in the presence of KCl
were signiﬁcantly enhanced by the presence of the
G-quadruplex-interactive agent telomestatin, raising the
possibility that telomestatin interacts with G-quadruplex
structure(s) formed by the G-rich sequence within this
tract (18). We also observed that selected G-quadruplex-
interactive agents could inhibit the messenger RNA
(mRNA) expression of these genes in various human
cancer cells, including kidney cancer cells, suggesting
that the transcription of these genes can be controlled by
ligand-mediated G-quadruplex stabilization (20). Taken
together, our previous studies provide critical support
for the idea that G-quadruplex structures may play struc-
tural roles in vivo and therefore provide insight into novel
methodologies for rational drug design.
In the present study, in order to obtain more direct
evidence for the existence of the G-quadruplex structures
in the pPu/pPy region of the VEGF proximal promoter,
we employed both in vitro and in vivo DMS footprinting
techniques and utilized a nucleolin protein to detect these
structures. DMS footprinting is known to be particularly
useful for probing G-quadruplexes in vitro, because these
structures require N7 of guanine and there is protection of
the guanine residues involved in G-quadruplex formation
from N7 methylation by DMS (21). Nucleolin is an
abundant nucleolar protein that has been implicated in
remodeling the chromatin structure, rDNA transcription,
rRNA maturation, ribosome assembly and nucleo-
cytoplasmic transport (22–23). Nucleolin is also reported
to be a G-quadruplex binding protein that binds tightly
and speciﬁcally to both the four-stranded and the two-
stranded G-quadruplex DNA with a nanomolar dissoci-
ation constant for binding (24). Recently, we also found
that nucleolin binds in vitro to the c-Myc G-quadruplex
structure with high afﬁnity and to other known
quadruplex structures (25). Overall, the results of our
study described here strongly support the presence of
G-quadruplex structures in the promoter region of the
VEGF gene both in vitro and in vivo.
MATERIALS AND METHODS
Cell culture
The A-498 renal cancer cell line was obtained from ATCC
and the cells were cultured in RPMI-1640 media (GIBCO
BRL) supplemented with 10% heat-inactivated fetal
bovine serum in a humidiﬁed atmosphere containing 5%
CO2 at 37 C.
Figure 1. (A) Schematic representation of the human VEGF gene promoter region containing the polypurine/polypyrimidine tract proximally
located at the transcription initiation site. Five G-repeats within this tract are indicated in open boxes (GR-1-GR-V). (B) Schematic representation
of the hydrogen-bonded G-tetrad. (C) Schematic illustration of a major parallel G-quadruplex structure formed by the VEGF G-rich single strand in
the presence of K
+. The guanine residues involved in the formation of tetrads are underlined.
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For in vitro footprinting of the VEGF promoter region,
we used the supercoiled form of the luciferase reporter
plasmid pGL3-VEGFP, which was constructed by
ligating an 837-bp VEGF promoter region (–787 to +50
relative to the transcription initiation site) into the KpnI
and NheI sites of pGL3-basic basic vector (Promega,
Madison, WI, USA), as described previously (10).
DMS Footprinting of the VEGF G-rich single strand
The
32P-labeled VEGF G-rich single strand d(CCCCGGG
GCGGGCCGGGGGCGGGGTCCC) was denatured
by heating at 90 C for 5min and then cooled slowly
to room temperature for 2–3h in 20mM Tris–HCl
buffer with 100mM KCl. The annealed DNA (20ml)
was treated with 1% DMS for 2min to methylate DNA
and modiﬁcation reactions were stopped by adding 80ml
stop buffer containing 0.3M NaOAC (pH 6.0) and 3mg
of calf thymus DNA, ethanol precipitated twice, and
treated with piperidine (10%). After hot piperi-
dine treatment, the cleaved products were resolved
on a 16% denaturing polyacrylamide gel as described
previously (20).
Electrophoretic mobility shift assay
To determine the binding of nucleolin to the VEGF
G-quadruplex, the VEGF G-rich single strand d(CCCC
GGGGCGGGCCGGGGGCGGGGTCCC) was
50-end-labeled with
32P, denatured by heating at 90 C
for 5min, then slow-cooled to room temperature with
100mM KCl to allow the formation of G-quadruplex
structures in the DNA oligomer. This folded DNA
oligomer was incubated with puriﬁed recombinant
maltose-binding protein (MBP)–nucleolin fusion proteins
(MBP-nucleolin) to form protein–DNA complexes, and
then subjected to a 5% or 8% native polyacrylamide gel
electrophoresis (PAGE) to separate the nucleolin–
G-quadruplex complex from unbound DNA. This
MBP-tagged nucleolin carries human nucleolin residues
284–709 (pNuc-1,2,3,4-RGG9), including all four RNA-
binding domains (RBDs) and the C-terminal domain,
and is fused at the N terminus to Escherichia coli
maltose-binding protein as described previously (25). In
control experiments, the corresponding VEGF C-rich
single strand d(GGGACCCCGCCCCCGGCCCGCCCC
GGGG), the mutant VEGF G-rich single strand d(CCCC
GGGGCGGGCCGGCGGCGGGGTCCC), and the
VEGF oligomer duplex were also used.
Chromatin immunoprecipitation assays
The occupancy of the VEGF promoter by nucleolin and
RNA polymerase II in vivo was determined by the chro-
matin immunoprecipitation (ChIP) assay as previously
described (26). In brief, A-498 cells were grown to
80–90% conﬂuence in 15-cm culture plates. After cross-
linking with 1% formaldehyde in serum-free medium
for 10min, phosphate-glycine buffer was added to a ﬁnal
concentration of 0.125M and cells were washed twice with
ice-cold phosphate-buffered saline (PBS). The chromatin
lysate was sonicated on ice to an average DNA length of
400bp. Chromatin was pre-cleared with blocked
Sepharose A, and immunoprecipitation was performed
with mouse monoclonal anti-nucleolin, anti-Sp1 and
anti-RNA polymerase II antibodies and 8mg of mouse
IgG as the negative control. All antibodies and IgG
were obtained from Santa Cruz Biotechnology.
Following an initial 5-min denaturation at 95 C, the poly-
merase chain reaction (PCR) ampliﬁcation involved 40
cycles of 94 C for 60s, 55 C for 30s, 72 C for 30s using
32P-50-end labeled primers designed to the proximal
promoter region (–242 to +48) of VEGF [forward d(TC
GCTCGCCATTGGATCTCGAGGA)3 and reverse d(G
CCCGACACACTGGCCGAAGCGACGA)] and the
proximal promoter region (–273 to +71) of HIF-1
[forward d(TCGCTCGCCATTGGATCTCGAGGA)
and reverse d(GCCCGACACACTGGCCGAAGCGAC
GA)]. PCR was also performed using primers designed
to a nonspeciﬁc promoter region 1kb upstream
( 1079 to  874) of the transcription start site of VEGF
[forward d(CCTCAGTTCCCTGGCAACATCTG) and
reverse d(GAAGAATTTGGCACCAAGTTTGT)]. All
PCR ampliﬁcation reactions were then analyzed on a
6% nondenaturing PAGE and visualized with a
Phosphorimager (Molecular Dynamics).
Polymerase chain reaction
Template complementary DNA (cDNA) was prepared
from total RNA extracted from A-498 cells using an
RNeasy mini kit (Qiagen, Valencia, CA, USA), according
to the manufacturer’s protocol. VEGF and actin cDNAs
were detected by PCR using forward and backward
primers speciﬁc for each gene. Primer sequences for
the VEGF gene were designed against a common region
to all isoforms of the VEGF mRNA: forward
primer, d(TGCATTGGAGCCTTGCCTTG) (nucleotides
1054–1073 from NM 003376.4); reverse primer, d(CGGC
TCACCGCCTCGGCTTG) (nucleotides 1664–1683 from
NM 003376.4). In parallel, the ampliﬁcation of b-actin
cDNA was done as an internal standard according
to the manufacturer’s protocol (Ambion). All of the
reactions involved an initial denaturation at 95 C for
3min, followed by 40 cycles for VEGF or 30 cycles for
b-actin at 94 C for 30s, 55 C for 30s and 72 C for 40s on
a GeneAmp PCR system 9600 (Perkin-Elmer).
In vitro footprinting of the VEGF promoter region with
DMS
A supercoiled form of the plasmid pGL3-VEGFP was
incubated in the presence of 100mM KCl at 37 C for
1h and then treated with DMS (0.2%) for 2min as previ-
ously described (27). DNA was precipitated with ethanol
and resuspended in double-distilled water after vacuum
drying. To map DMS reactive sites on the plasmid
DNA, linear ampliﬁcation by PCR was performed using
Thermo Sequenase Cycle Sequencing kit (USB) with a
32P-labeled gene-speciﬁc primer 1V d(CCCAGCGCCAC
GACCTCCGAGCTACC) spanning +23 and +49 of the
promoter region to amplify the top strand of the plasmid
DNA as previously described (20). PCR was carried out
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naturation step at 94 C, 1min at 60 C and 1min at 72 C,
for a total of 40 cycles. Sequencing ladders (A, G, T and
C) as size markers were generated by the dideoxy method
with a
32P-labeled gene-speciﬁc primer 1V and the plasmid
pGL3-VEGFP.
In vivo genomic footprinting with DMS
A498 cells were incubated for 48h with and without
TMPyP4 at the IC50 concentration (50mM). For DMS
footprinting, cells were washed with PBS and then
incubated with PBS containing 2% DMS for 2min.
Treated cells were lysed and incubated overnight with
DNA lysis buffer (50.0mM Tris–HCl, pH 8.5, 50mM
NaCl, 25mM EDTA, pH 8.0, 0.5% SDS and 300mg/ml
of proteinase K), and genomic DNA was puriﬁed
by phenol–chloroform extraction and ethanol precipita-
tion. The DNA was cleaved with piperidine and the
cleavage sites were identiﬁed by LM-PCR as described
below (28).
Ligation-mediated PCR
The isolated genomic DNA, after piperidine treatment,
was analyzed by ligation-mediated (LM)-PCR to map
the cleavage sites on the (+) strand of the VEGF
promoter region (28). The ﬁrst-strand synthesis was ac-
complished with a gene speciﬁc primer 1V d(CCCAGCG
CCACGACCTCCGAGCTACC) spanning +23 and +49
of the promoter region annealed on genomic DNA and
Vent DNA polymerase (New England Biolabs) using a
thermal cycle of 10min at 95 C, 30min at 60 C and
10min at 76 C as previously described (28). The reaction
mixtures were extracted once by phenol–chloroform and
precipitated with ethanol to purify DNA. The puriﬁed
DNA was then ligated with 100pmol of unidirectional
linker L11 d(GAATTCAGATC) and L26 d(GCGGTGA
CCCCGGGAGATCTGAATTC) in 20ml of ligation
solution [250 mM Tris–HCl (pH 7.7)/10mM MgCl2/
20mM dithiothreitol/3mM ATP/0.005% bovine serum
albumin/20U of T4 DNA ligase (Promega)]. After incu-
bation for 12–16h at 17 C, samples were extracted once
by phenol–chloroform and precipitated with ethanol to
purify and concentrate DNA. The puriﬁed ligated
DNAs were ampliﬁed by PCR using a nested primer 2V
d(CCCGGCTGCCCCAAGCCTCCGCGA) spanning+1
and +23 and the linker oligonucleotide (L26). PCR was
carried out using cycling conditions consisting of an initial
4-min denaturation step at 94 C, 1min at 60 C and 1min
at 72 C, for a total of 40 cycles. Labeling of the (+) strand
was performed with
32P-end-labeled nested primer 2V.
Subsequently, the samples were phenol–
chloroform-extracted, ethanol-precipitated, resuspended
in sequencing loading buffer and separated in 10% poly-
acrylamide, 7M urea sequencing gels. Sequencing ladders
(A, G, T and C) as size markers were generated by the
dideoxy sequencing method with a gene speciﬁc primer 1V
and the plasmid pGL3-VEGFP.
RESULTS
Formation of G-quadruplex structures by the G-rich
strand of the pPu/pPy tract of the VEGF promoter
DMS footprinting is useful for ﬁne mapping the presence
of G-quadruplex structures within the promoter region
(20,21). The formation of G-quadruplex structures
requires N7 of guanine, which is subsequently protected
from N7 methylation by DMS (20,21). Consistent with
our previous studies (20), DMS footprinting revealed
that a unique G-quadruplex structure is formed in the
G-rich single strand of the pPu/pPy tract of the VEGF
promoter region. This tract has the capacity to form a
unique intramolecular G-quadruplex structure in the
presence of K
+, which requires four guanine blocks
(GR-I to GR-IV), consisting of 12 total guanines
(Figure 1A). DMS cleavage of the VEGF G-rich single
strand showed that three stacked G-tetrads formed by
four G-stretches were protected from methylation by
DMS (except one guanine residue indicated by an
asterisk), whereas two guanine residues within the central
loop showed hypersensitivity to DMS (Figure 2A, lane 1).
We further examined G-quadruplex formation in the
promoter DNA duplex of the VEGF gene (787 to +50)
using in vitro DMS footprinting experiments with a super-
coiled form of plasmid pGL3-VEGFP. As shown in
Figure 2B (lane 4), under supercoiled conditions DMS
shows dramatically reduced reactivity within the four
50-end runs of guanines (bracket ‘G40) on the G-rich
strand of the pPu/pPy tract of the VEGF promoter
region, where G-quadruplex structures are proposed to
be present. In contrast, the ﬂanking regions (Brackets
‘UF’ and ‘DF’) of the proposed G-quadruplex-forming
sequence show enhanced reactivity to DMS (Figure 2B,
lane 4), presumably because of the presence of locally
unwound structures at the junctions between normal
duplex regions and stable secondary structures.
Interestingly, a moderate reactivity of DMS toward
some of the guanine residues from GR-III was found,
suggesting a loop region of the G-quadruplex structures
as observed in studies using a single-stranded G-rich DNA
(Figure 2A, lane 1). The reactivity of DMS toward the
guanine residues within the complete G-rich region is
normal in the linearized form of plasmid pGL3-VEGFP
(Figure 2C, lane 4), showing that negative supercoiling is
required to drive the local unwinding of the pPu/pPy tract,
allowing a speciﬁc G-rich region to form a G-quadruplex.
The results of DMS footprinting for the VEGF G-rich
single strand and the G-rich region within a supercoiled
plasmid pGL3-VEGFP in the presence of 100mM KCl
are summarized in Figure 2D.
In vivo DMS footprinting
The DMS-based genomic footprinting analysis of the
VEGF promoter was carried out to investigate the poten-
tial link between alterations in DNA conformation and
changes in gene expression using A498 cells as a model
cell line. We ﬁrst examined the effects of
G-quadruplex-interactive agents on the expression of the
VEGF gene in A498 renal carcinoma cells using TMPyP4
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low afﬁnity for G-quadruplexes (29). The IC50 values
for both TMPyP2 and TMPyP4 in A-498 cell lines were
 50mM when their antiproliferative activities were
assessed with the MTT assay. The treatment of A498
cells with 25 and 50mM TMPyP4 resulted in a signiﬁcant
repression of VEGF gene expression after 48h, while
TMPyP2 did not cause a decrease in VEGF gene expres-
sion (Figure 3A). This result suggests that the
G-quadruplex-binding activity of TMPyP4 is responsible
for reducing the transcription of the VEGF gene in the
presence of TMPyP4. Next, in vivo DMS footprinting via
LM-PCR of the G-rich strand of the pPu/pPy tract of the
VEGF promoter was carried out to determine the
presence of G-quadruplex structures within this region.
As shown in Figure 3B, genomic DMS footprinting
analysis of the VEGF promoter revealed that the three
guanine repeats at the 30 side of the G-rich strand of the
VEGF promoter were strongly protected, while remark-
able DMS hypersensitivity sites in vivo were found at
guanine residues located at the third guanine repeat
(GR-III) (Figure 3B, lane 1). This unusual hypersensitivity
is believed to be the result of enhanced reactivity of DMS
toward the guanine residues located in the loop region of
the G-quadruplex structures formed within the pPu/pPy
tract of the VEGF promoter region. A similar observation
was made in in vitro DMS footprinting experiments using
a supercoiled plasmid DNA as shown in Figure 2B (lane
4). It is worthwhile to note that G-quadruplex DNA struc-
tures formed at this region in vivo might differ from those
formed in vitro because two hypersensitive guanine
residues in the GR-III from the in vivo protection experi-
ment do not correspond to the loop guanines presented in
our VEGF G-quadruplex model deducted from in vitro
experiments. Densitometric scans (Figure 3C) of the auto-
radiogram in Figure 3B revealed that DMS protection was
only slightly enhanced within the same region of the
G-rich strand following TMPyP4 treatment (Figure 3B,
lane 2). This result suggests the presence of a permanently
folded DNA structure into a G-quadruplex in vivo at the
pPu/pPy tract of the VEGF promoter even in the absence
of G-quadruplex-interactive agents, such as TMPyP4.
Next, we performed ChIP assays to examine whether the
recruitment of Sp1 and RNA polymerase II to the VEGF
gene promoter is attenuated by TMPyP4 consistent with
reduced transcription of this gene in the presence of
TMPyP4 (Figure 3A). The treatment of A498 cells with
50mM TMPyP4 for 48h resulted in decreased recruitment
of Sp1 and RNA polymerase II to the VEGF promoter
DNA as shown in Figure 3D. This result suggests that the
interaction of TMPyP4 with G-quadruplexes in the VEGF
promoter would prevent the binding of Sp1 and RNA
Figure 2. (A) DMS footprinting of the VEGF G-rich single strand in the presence of 100mM KCl. AG and TC lanes represent purine and
pyrimidine- speciﬁc Maxam–Gilbert sequencing reactions, respectively. Lanes 1 and 2 correspond to the G-rich strand DMS treated and untreated,
respectively. (B and C) Autoradiogram showing DMS modiﬁcation sites on the G-rich strand of a supercoiled (B) or linearized (C) form of
pGL3-VEGF plasmid. Lanes 1 and 2 represent respective cytosine and guanine-speciﬁc dideoxysequencing reactions using the same primer as for
the extension reactions. Lanes 3 and 4 correspond to the pGL3-VEGF plasmids that are untreated and treated with DMS (0.25%), respectively. Each
band reﬂects extension reaction products of a gene speciﬁc primer designed to anneal to the G-rich strand of the plasmid DNA to map the DMS
modiﬁcation sites on the same strand. The bracket ‘G4’ represents a proposed G-quadruplex-forming region and brackets ‘UF’ and ‘DF’ represent
the up- and downstream ﬂanking regions of the G-quadruplex-forming sequence. (D) Summary of the results from both DMS footprinting
experiments. The DMS-protected guanine residues within the G-rich sequences of the VEGF promoter are indicated by open circles, and closed
circles indicate the guanine residues methylated by DMS. Data shown are representative of at least two experiments.
1260 Nucleic Acids Research, 2011,Vol.39, No. 4polymerase II to the VEGF promoter in vivo, resulting in
repression of the VEGF gene. These results also support
our hypothesis that enhanced protection of guanine
residues from methylation by DMS is not simply due to
the increased association of nuclear proteins, but to the
formation of G-quadruplex structures as well. The results
from both footprinting experiments are summarized in
Figure 3E and F.
Figure 3. (A) RT-PCR analysis of VEGF expression in A498 cells treated with DMS vehicle (control), 50mM TMPyP2 (P2) or 25 and 50mM
TMPyP4 (P4) for 48 and 72h. (B) In vivo DMS footprinting analysis of the VEGF promoter region in A498 cells treated for 24h with DMS vehicle
(lane 1) or 50mM TMPyP4 (lane 2). Lanes A, G, T and C represent the products of sequencing reactions with the same template as a size marker.
Lane M represents a 109-bp-sized marker. (C) Densitometric scans of the autoradiogram in (B). The gray bars indicate the guanine repeats, which
are involved in G-quadruplex formation. (D) ChIP analysis to determine the effect of TMPyP4 on recruitment of RNA polymerase II and Sp1 to the
VEGF promoter region containing the polypurine/polypyrimidine tract in A498 renal carcinoma cells treated with either DMSO control or 25mM
TMPyP4 for 48h. Recruitment of RNA polymerase II (Pol II) and Sp1 to the VEGF proximal promoter was assessed using primers speciﬁc to the
VEGF promoter. One percent of total input DNA was used as a loading control (input), and isotype-matched IgG was used as an internal control for
the immunoprecipitation (IgG). (E) Proposed equilibrating forms of the pPu/pPy tract of the VEGF promoter in genomes. The asterisks indicate the
guanine residues within the G-quadruplex-forming region that show hyperreactivity toward DMS, because they may be located within the locally
unwound region or loop region of the G-quadruplex structures. (F) Summary of the results from both in vitro and in vivo DMS footprinting
experiments. The DMS-protected guanine residues within the G-rich sequences of the VEGF promoter are indicated by open circles, and closed
circles indicate the guanine residues either methylated or hypermethylated by DMS. Data shown are representative of at least two experiments.
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nucleolin to verify the presence of G-quadruplex
structures in the promoter region of the VEGF
gene in vitro and in vivo
In this study, we utilized nucleolin as a probe for
G-quadruplex structures to identify their presence in the
promoter region of the VEGF gene both in vitro and
in vivo based on the assumption that nucleolin could
bind to the G-quadruplex structures formed by this
tract. We ﬁrst conﬁrmed the binding of nucleolin to the
intramolecular G-quadruplex structure formed by the
G-rich strand of the VEGF proximal promoter region.
To determine the binding of nucleolin to the VEGF
G-quadruplex, a 50-end
32P-labeled DNA oligomer,
spanning the G-quadruplex-forming region of the G-rich
sequence, was folded into G-quadruplex structures as
described in the ‘Materials and Methods’ section. This
folded DNA oligomer was incubated with nucleolin to
form protein–DNA complexes, and then subjected to a
native PAGE to separate the nucleolin–G-quadruplex
complex from unbound DNA by the difference in the
electrophoretic mobility. As shown in Figure 4A, the
VEGF G-quadruplex forms a complex with nucleolin,
while a complementary C-rich strand (Figure 4B),
VEGF duplex oligomer (Figure 4C), and PCR-ampliﬁed
202bp duplex DNA containing the proximal promoter
region of the VEGF gene (Figure 4D), fail to form a
complex with nucleolin, indicating a possible interaction
of the VEGF-G-quadruplex with nucleolin. The results of
competition experiments shown in Figure 4E also con-
ﬁrmed that nucleolin was able to speciﬁcally bind to the
VEGF G-quadruplex. A 5-fold excess of the VEGF
G-rich strand prevented the binding of nucleolin, while a
10-fold excess of the mutant VEGF-G-rich strand had no
effect.
In our previous study, it was demonstrated that the
transition of B-form DNA to G-quadruplexes occurs at
the G-rich strand of the pPu/pPy tract of the VEGF
promoter region under negative supercoiling stress (18).
This suggests that negative supercoiling could generate
binding sites for nucleolin on this tract. Thus, DNase I
footprinting was used to determine the binding of
Figure 4. (A) Nucleolin binding to the intramolecular G-quadruplex structure formed by the G-rich strand of the VEGF proximal promoter region.
The VEGF G-quadruplex incubated with various concentrations of nucleolin to determine the formation of the complex with nucleolin. (B–D) The
complementary VEGF C-rich strand (B), VEGF oligomer duplex (C) and PCR-ampliﬁed duplex DNA representing the proximal promoter region of
the VEGF gene (D) were incubated with various concentrations of nucleolin to determine the formation of complex with nucleolin. (E) Competition
experiments to measure the speciﬁcity of nucleolin binding to the VEGF G-quadruplex. Two different amounts of competitors were added to the
binding reaction with 1mg nucleolin. Lanes 2–4 are competition experiments with mutant G-strand (Mt-G-strand) competitors at 0 ,5   and 10 ,
respectively, and lanes 5–7 are competition experiments with the VEGF-G-strand at 0 ,2   and 5 , respectively. The ‘C’ and ‘F’ in panels A–E
represent the complex and free form of DNA with nucleolin, respectively. (F) Nucleolin binding to the pPu/pPy tract of the VEGF proximal
promoter region in supercoiled plasmid DNA. DNase I footprinting was used to determine the binding of nucleolin to the promoter region of the
VEGF gene with the plasmid pGL3-VEGFP, which contains the VEGF promoter region from –787 to+50. The bracket ‘G4’ represents a proposed
G-quadruplex-forming region and brackets ‘UF’ and ‘DF’ represent up- and downstream ﬂanking regions of the G-quadruplex-forming sequence.
Data shown are representative of at least two experiments.
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the plasmid pGL3-VEGFP, which contains the VEGF
promoter region from  787 to +50. In this experiment,
nucleolin was incubated with pGL3-VEGFP in the
absence or presence of 50mM KCl at 37 C for 1h and
then probed with DNase I as described previously. DNase
I cleavage sites in the plasmids incubated with nucleolin
were then mapped using linear ampliﬁcation by PCR with
32P-labeled gene-speciﬁc primers as described in ‘Materials
and Methods’ section. As shown in Figure 4F, the DNase
I protected region located at approximately  53 to
 123bp includes the predicted G-quadruplex-forming
region. This result suggests that nucleolin interacts with
G-quadruplex structure(s) formed by the G-rich sequence
within the pPu/pPy region of the VEGF gene.
Nucleolin can bind to the VEGF proximal promoter in cells
Next, we carried out a ChIP assay to determine whether
nucleolin is associated with the proximal promoter region
of the VEGF gene in A498 renal carcinoma cells. As
shown in Figure 5A, we observed the PCR ampliﬁcation
product of the proximal promoter region (–242 to +48)
after immunoprecipitation of the cross-linked chromatin
with the anti-nucleolin antibody (lane 5) in addition to the
anti-RNA polymerase II (lane 3) and anti-Sp1 antibody
(lane 4), while immunoprecipitates with puriﬁed mouse
IgG as a negative control resulted in no PCR ampliﬁed
products (lane 2). These results support the idea that
nucleolin as well as RNA polymerase II bind to the
VEGF promoter spanning the nucleotides from  242 to
+48, suggesting the presence of speciﬁc G-quadruplex
structures within the proximal promoter region of this
gene in vivo. To further determine the speciﬁcity of
nucleolin binding to the G-quadruplex-forming region,
we also ampliﬁed the 50 upstream promoter region (–
1079 to  874) of the VEGF gene, not containing any
putative G-quadruplex-forming regions, and no PCR
products indicative of the upstream region of the VEGF
promoter were found (Figure 5B). As a positive control,
we also ampliﬁed the proximal promoter region (–273 to
+71) of the HIF-1a gene, which contains a putative
G-quadruplex-forming region. As shown in Figure 5C,
PCR products indicative of this region were observed in
the input sample (lane 1), RNA polymerase, Sp1 and
nucleolin-speciﬁc immunoprecipitations.
DISCUSSION
The pPu/pPy tract ( 85 to  50 relative to transcription
initiation site) within the proximal promoter region of the
VEGF gene is essential for basal or inducible expression of
this gene in several human cancer cell lines (5, 10). The
G-rich strand of this tract contains four runs of at least
three contiguous guanines separated by one or more
bases, conforming to a general motif capable of forming
an intramolecular G-quadruplex (18,20). Our previous
studies demonstrated that this G-rich sequence is able to
form an intramolecular propeller-type parallel-stranded
G-quadruplex structure in vitro (20). Our other study also
revealed a signiﬁcant change in the digestion patterns
within this region with both DNase I and S1 nuclease
after the addition of KCl and telomestatin (18), suggesting
the possible interaction of the G-quadruplex-interactive
agent telomestatin with a G-quadruplex-forming region
within the VEGF gene in supercoiled DNA.
In this report, we have further examined the possible
presence of G-quadruplex structures both in vitro and
in vivo in the pPu/pPy tract within the proximal
promoter region of the VEGF gene using DMS and
nucleolin as chemical and protein probes, respectively.
DMS footprinting has been widely used for ﬁne
mapping of the presence of G-quadruplex structures
within G-rich single-stranded DNA since the formation
of G-quadruplex structures requires the N7 of guanine,
which is protected from N7 methylation by DMS
(19,21). Our recent study also demonstrated that DMS
footprinting is useful for probing G-quadruplexes within
the duplex DNA in vitro (27). As demonstrated in this
study, four consecutive guanine tracts at the 50 side of
the G-rich strand within the pPu/pPy tract of the VEGF
promoter, which are predicted to be involved in the for-
mation of the G-tetrad, show diminished reactivity to
DMS under supercoiled conditions. By contrast, the im-
mediate ﬂanking regions of the proposed G-quadruplex-
forming sequence show enhanced reactivity to DMS,
presumably because of the presence of locally unwound
structures at the junctions between normal duplex regions
and stable secondary structures. Interestingly, guanine
residues in a predicted central loop region showed hyper-
sensitivity to DMS. Overall, our ﬁndings in the present
study are in line with our hypothesis that G-quadruplex
structures could be formed by the G-rich strand of the
pPu/pPy tract within the VEGF promoter region and
these structures might participate in the regulation of
this gene’s transcription.
Figure 5. (A) ChIP analysis to determine the binding of nucleolin to
the VEGF promoter region containing the polypurine/polypyrimidine
tract in A498 renal carcinoma cells. Recruitment of RNA Polymerase
II (Pol II) (lanes 3), Sp1 (lanes 4) and nucleolin (lanes 5) to the VEGF
proximal promoter was assessed using primers speciﬁc to the VEGF
promoter (–248 to +48). One percent of total input DNA was used
as a loading control (lane 1) and isotype-matched IgG was used as
an internal control for the immunoprecipitation (lane 2). (B) PCR
ampliﬁcation of immunoprecipitated DNAs using primers speciﬁc to
the 50 upstream promoter region (–1079 to –874) of the VEGF gene
as a negative control. (C) PCR ampliﬁcation of immunoprecipitated
DNAs using primers speciﬁc to the proximal promoter region
( 273 to +71) of the HIF 1a gene as a positive control. Data
shown are representative of at least two experiments.
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of the pPu/pPy tract of the VEGF promoter also provided
interesting information regarding the possibility of the
presence of G-quadruplex structures within this region.
As described in Figure 3B, most of the protected
guanine residues correspond to those that are known to
be involved in the formation of G-quadruplexes in vitro.
This is consistent with the results of in vitro DMS foot-
printing of the G-rich strand in both a single-stranded and
double-stranded form in supercoiled DNA. Furthermore,
the presence of DMS-hypersensitive guanines within the
loop region of the predicted G-quadruplex structures on
the G-rich strand would reﬂect the presence of a stable
G-quadruplex within the VEGF promoter region.
However, two DMS-hypersensitive guanine residues
within the GR-III do not correspond to the loop
guanines presented in our VEGF G-quadruplex model
deducted from in vitro DMA protection experiments.
This implies the possibility that G-quadruplex DNA struc-
tures actually forming in this region in vivo might differ
from those observed in in vitro experiments. It is very dif-
ﬁcult to experimentally determine the G-quadruplex struc-
tures that actually exist in vivo. However, the possibility of
the existence of different forms of G-quadruplexes in vivo
cannot be completely excluded because the internal
nuclear environment could differ from those in vitro
with respect to ionic composition and concentration,
pH, protein composition and concentration, polyamine
concentration, etc. Interestingly, DMS protection was
only slightly enhanced within the same region of the
G-rich strand following TMPyP4 treatment, although
the occupancy of both Sp1 and RNA polymerase of the
proximal promoter region of the VEGF gene sharply
decreased after a 48-h incubation in the presence of
50mM TMPyP4. We speculate that TMPyP4 might not
signiﬁcantly facilitate the formation of G-quadruplexes
in this region, but would interact with the already-existing
G-quadruplexes. The G-quadruplexes complexed with
TMPyP4 could be more efﬁcient than G-quadruplex struc-
tures alone in preventing the transcription components,
such as Sp1 and RNA polymerase II, from binding to
the VEGF promoter region, thus resulting in reduced
expression of the VEGF gene. The result of ChIP assays
also supports the notion that enhanced protection of the
guanine residues from methylation by DMS in both un-
treated and TMPyP4-treated cells is due to the formation
of G-quadruplex structures rather than the increased
association of nuclear proteins.
In several previous studies, the abundant nucleolar
protein, nucleolin, has been shown to bind both intra-
and intermolecular G-quadruplex DNA with very high
afﬁnity (24,25), suggesting that G-quadruplex structures
are binding targets of nucleolin in vivo. Based on these
observations, we utilized a nucleolin protein as a struc-
tural probe to identify G-quadruplex structures formed
within the duplex DNA both in vitro and in vivo in this
study. In support of the pPu/pPy tract of the VEGF
promoter region having similar G-quadruplex structures
both in vivo and in vitro, DNase I footprinting of the
plasmid pGL3-VEGFP revealed the binding of nucleolin
to the G-quadruplex forming region of the VEGF
promoter. A ChIP assay further conﬁrmed the in vivo
binding of nucleolin to the VEGF promoter region
containing the pPu/pPy tract. The results presented
here support the use of nucleolin for both in vitro and
in vivo structural probing to identify the formation of
G-quadruplex structures within the G-rich sequences
that affect transcription of many mammalian genes
in vivo. The results with both in vitro and in vivo DMS
footprinting experiments show that predictions of intra-
cellular G-quadruplex structures, especially structures
involving local interactions, can be made on the basis of
in vitro reactivity of DMA toward the guanine residues
involved in the formation of these structures.
Several lines of experimental evidence from previous
studies support a potential formation of G-quadruplex
structures in the promoter region of the VEGF gene
(18,20). Our ﬁndings from this study further provide
strong evidence that the G-rich region within pPu/pPy
tract of the VEGF promoter region could adopt stable
G-quadruplex structures, which could be probed with
DMS both in vitro and in vivo. In conjunction with
DMS footprinting, protein probes such as nucleolin,
which speciﬁcally recognize G-quadruplex structures,
could be used to investigate whether G-quadruplex struc-
tures are formed in vitro and in vivo from putative
G-quadruplex forming sequences. Our results also
support the idea that nucleolin can function as a transcrip-
tional regulator of mammalian genes (25), whose
promoter regions are able to form G-quadruplex struc-
tures under physiological conditions. Thus, ongoing
studies are in progress in our laboratory to deﬁne a
possible role for nucleolin in regulating transcription of
the VEGF gene. Although it is not yet known whether
these noncanonical DNA structures can serve as a
substrate for these transcription factors in an in vivo
system, their speciﬁc interaction with non-B-DNA struc-
tures in an in vitro system suggests that alternative DNA
conformations may naturally exist and may also play a
crucial role in the regulation of many genes containing
highly dynamic conformations in their promoter regions.
Such alternative structures, although speculative at this
point, may be of relevance for the new therapeutic
approach that proposes the use of small molecule drugs
as transcriptional regulators.
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